Recent product updates and feature launches. We ship continuously and keep this page current so you can see what changed before you sign in.
All 16 specialty corpora have been re-embedded with a model better suited to biomedical text. You should notice more on-target papers coming back from search, especially on mechanism-heavy questions where precise terminology matters. The evidence map clusters papers more tightly along stance and topic.
No action needed. Existing sessions and saved corpora pick up the improvement automatically.
The UMAP layout on the semantic plot can take a few minutes to compute on larger libraries. A small confirmation now appears when you select it, so you can decide whether to wait or pick the faster MDS or Auto options instead. The UMAP button now also carries a small caution mark to signal that it's the heavier choice.
The home page got a substantial visual and copy refresh, the workflow now formally includes the evidence map as its own stage, and a coming-soon teaser is up for a kid-facing companion product.
The workflow diagram on the home page now shows six stages instead of five, with the evidence map sitting between adversarial review and experimental design. This matches how the product actually works: the debate produces a navigable map of every cited paper, then the design step builds on that grounding.
Feature headlines now render in Manrope, a modern sans-serif that reads as designed rather than default. The two-turtles wordmark in the top nav picked up a subtle two-layer drop shadow so it sits slightly above the page rather than floating flat.
The semantic plot endpoint now caches results by content fingerprint. If you reload the same evidence map, open a second tab on the same session, or come back after navigating away, the plot now appears almost instantly instead of recomputing. The cache is shared across all users, so common projections also stay warm for everyone.
A kid-facing companion product launched at colo-sci.com/learn. Two friendly turtles named Lewis and Sage take turns answering science questions in plain words, aimed at elementary and middle-school curiosity. Features include voice readout, karaoke text that highlights as the turtles speak, and on-demand pictures for visual learners. Built as a separate app rather than a voice toggle inside the researcher product, since the audience and the UX needs are fundamentally different.
The Tone selector on every workflow page lists a fourth tier, 🧒 Curious, which opens the kids' app in a new tab. There is also a "Try Colo for Kids" button in the top-left of the nav on the home page.
The biggest data update since launch. Colo's indexed PubMed library doubled in coverage and roughly tripled in size, with eight new specialty domains added on top of the original eight.
The setup page shows all 16 specialty pills, each expanding to the subdomains within it (cardiology unfolds into heart failure, atrial fibrillation, stroke, hypertension, and so on). Pick one or several; Colo routes your retrieval to just those specialties. Total searchable corpus is now 3.4 million peer-reviewed PubMed abstracts.
Under the hood, each specialty now lives in its own dedicated index rather than one giant unified database. Queries against a specific specialty route directly to that index instead of filtering across everything, which makes searches noticeably faster for typical single-specialty work and prevents the timeout errors that occasionally surfaced on metadata-filtered queries.
The mindmap is no longer tucked inside the export view. It now has its own dedicated page in the workflow chain, sitting between adversarial review and methods design.
Setup → Adversarial → Mindmap → Methods → Scaffold → Export. The mindmap page carries the full session context forward and classifies every cited paper into supporting, unresolved, or challenging stances. The same visual you've been using in the export view, now first-class in the flow.
The mindmap had always been one of the most-asked-about parts of Colo, but it was hard to find buried under the export step. Lifting it out gives you a deliberate place to pause, look at where the evidence sits, and decide whether the debate covered enough ground before continuing to design.
Free accounts can now run the full first four turns of an adversarial debate without entering payment information. After the fourth turn, the workflow transitions to a paywall card for methods, scaffold, and additional turns. The mindmap step is visible on the free tier so you can see what the debate produced before deciding whether to continue.
Colo now adapts how its agents talk based on where you are in your research career. Three active tiers, picked once from your account page and toggleable from any workflow screen, change how technical the explanations are without changing the rigor of the science.
Expert: Reserved for the post-launch update when Expert mode goes live. The tier card is visible, the voice tuning is still being calibrated.A fourth tier, 🧒 Curious, is visible on the account page marked "Coming soon." That tier will ship as a separate workspace tuned for K-12 and early-stage learners, not as a voice toggle inside the researcher product. Different audience, different surface.
The homepage now has a small chat window in the bottom right. Tap the mascot to ask questions about how Colo works, what makes the synthesis trustworthy, or where to start. It is meant for visitors deciding whether to try the workspace, not for running an actual synthesis.
Researchers who don't need a monthly commitment can now buy synthesis credits in one-time packs. Same workflow access as the Researcher subscription, but billed only for what you actually generate.
/pricing now shows subscription and pay-as-you-go side by side as two ways to pay for the same product, rather than two separate tiers. The shared feature list at the top covers what both options unlock; the columns below cover the cost model.
The mindmap composer in the export view now offers three different ways to look at the same set of cited papers, and the home page hero card lets you flip between a stance-clustered list and a semantic projection.
A new ↻ Update button on the mindmap composer re-runs the classifier across the full session. If your debate kept going past the point where the mindmap was first generated, one click brings the visualization back in sync.
The hero card on colo-sci.com now flips between the stance-column view and a semantic scatter of the same 16 papers. Click any dot for the paper's stance, year, summary, and a direct link to PubMed.
A new 📊 button at the bottom of the adversarial chat opens a popover showing exactly how many calls and tokens your current session has consumed, broken out by stage (setup, intake, adversarial debate, mindmap classifier).
Useful for researchers who need to estimate cost on their own side, and for anyone curious where their session's token budget is actually going.
The roadmap below isn't a guarantee, but it is what the immediate product investment is going toward. If any of these are blocking a workflow you care about, the support page reaches a real human.
A small Credits remaining indicator next to the existing token tracker on workflow pages, so pack users can see their balance burn in real time. Soft warning banners at 80% and 95% used.
When a session runs out of credits mid-flow, a top-up modal pre-loaded with the three pack options will appear in place of a generic "out of credits" error.
Currently the methods and scaffold pages reason from the hypothesis and adversarial transcript. A "Grab more papers" button will let you pull additional PubMed evidence into the conversation context for both pages, with the agents citing retrieved PMIDs inline as they design study methods or build grant Specific Aims.
Coming soon: when you revisit a session's evidence map after the first view, it will appear almost instantly instead of recomputing. The cache will refresh automatically as new papers come in.
Today the methods page locks you into one study type per session (RCT, in vitro, cohort, etc). Many real research programs are hybrid: a translational arc that pairs in vitro mechanism work with a cohort validation, or an RCT with a parallel preclinical sub-study. We're scoping a workflow that lets a single session design across multiple study types in one structured plan, with shared endpoints and aligned timelines. This is a larger build and won't ship soon, but it's on the roadmap.